José García Arumí-rekin lankidetzan egindako argitalpenak (20)

2022

  1. A Screening Tool for Self-Evaluation of Risk for Age-Related Macular Degeneration: Validation in a Spanish Population

    Translational Vision Science and Technology, Vol. 11, Núm. 6

2021

  1. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

    Acta ophthalmologica, Vol. 99, Núm. 8, pp. 861-870

2020

  1. Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829

  2. Reply

    Retina (Philadelphia, Pa.)

  3. Surgical options for optic disc pit maculopathy: Perspectives and controversies

    Clinical Ophthalmology, Vol. 14, pp. 1601-1608

2019

  1. Efficacy of Internal Limiting Membrane Flap Techniques with Vitrectomy for Macular Detachment Associated with an Optic Disc Pit

    Ophthalmologica, Vol. 242, Núm. 1, pp. 38-48

  2. PREOPERATIVE VITREORETINAL INTERFACE ABNORMALITIES ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY AS RISK FACTOR FOR PSEUDOPHAKIC CYSTOID MACULAR EDEMA AFTER PHACOEMULSIFICATION

    Retina (Philadelphia, Pa.), Vol. 39, Núm. 11, pp. 2225-2232

2017

  1. Eficacia del tratamiento inmunomodulador con interferón-β o acetato de glatirámero en las uveítis asociadas a esclerosis múltiple

    Archivos de la Sociedad Española de Oftalmologia, Vol. 92, Núm. 6, pp. 273-279

2015

  1. Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration

    Journal of Ophthalmology, Vol. 2015

  2. Predicting proliferative vitreoretinopathy: Temporal and external validation of models based on genetic and clinical variables

    British Journal of Ophthalmology, Vol. 99, Núm. 1, pp. 41-48

2014

  1. A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration

    Journal of Ophthalmology, Vol. 2014

2011

  1. Myopic choroidal neovascularization

    Ophthalmology

2010

  1. A strong genetic association between the tumor necrosis factor locus and proliferative vitreoretinopathy: The Retina 4 Project

    Ophthalmology, Vol. 117, Núm. 12

2008

  1. Burden of illness of bilateral neovascular age-related macular degeneration in Spain

    Current Medical Research and Opinion

  2. Non-complicated retinal detachment management: Variations in 4 years. Retina 1 project; report 1

    British Journal of Ophthalmology, Vol. 92, Núm. 4, pp. 523-525

  3. Surgical outcomes for primary rhegmatogenous retinal detachments in phakic and pseudophakic patients: The Retina 1 Project - Report 2

    British Journal of Ophthalmology, Vol. 92, Núm. 3, pp. 378-382

2006

  1. Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening

    Ophthalmic Research, Vol. 38, Núm. 4, pp. 193-200

2005

  1. Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy

    Current Eye Research, Vol. 30, Núm. 2, pp. 147-153

2003

  1. Factores clínicos de riesgo para el desarrollo de la vitreorretinopatía proliferante (VRP) postquirúrgica: Estudio prospectivo

    Archivos de la Sociedad Española de Oftalmologia, Vol. 78, Núm. 2, pp. 91-97

  2. Proliferative vitreoretinopathy: Cytologic findings in vitreous samples

    Ophthalmic Research, Vol. 35, Núm. 4, pp. 232-238